Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
24.02.2025 13:05:11

EQS-News: REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market

EQS-News: REMSleep Holdings / Key word(s): Financial
REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market

24.02.2025 / 13:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


CLEARWATER, FL - February 24, 2025 (NEWMEDIAWIRE) - REMSleep Holdings, Inc. (OTC: RMSL) announces the launch of new updated website dedicated for the launch of the new FDA cleared Deltawave nasal pillows CPAP mask.  The Deltawave is available to the market through the website.  We project first orders can be processed and available for shipment in approximately three weeks.  We are setting up an assembly, packaging, and shipping center dedicated to REMSleep products. 

We have filed for the REMSleep Medicare number and expect to have REMSleep Medicare number in approximately 30 days. REMSleep has sent samples of The Deltawave mask to large distributors for their review.  We obviously cannot disclose these distributors at this time, but we are corresponding with these distributors and hope to have more information in the near future.  We can say we have had a very positive response from these distributors.  Deltawave offers a new level of treatment for sleep apnea that has not been available.  Distributors and health care professionals will love and appreciate the therapeutic value and benefits of Deltawave for their sleep apnea patients.  We will soon focus on bringing the second-generation Longevity CPAP mask to market.  REMSleep CPAP masks will bring unprecedented compliance to CPAP treatment.

About REMSleep Holdings, Inc.

REMSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make a difference and improve the condition of those suffering from sleep apnea.

Forward-looking Statements

This press release may contain forward-looking statements regarding the Company. All statements, other than statements of historical fact included herein, are "forward-looking statements" including statements regarding the Company’s future prospects and risks in investing in Company’s common stock. These statements are based upon the Company's current expectations and speak only as of the date hereof. Financial performance in one period does not necessarily mean continued or better performance in the future. The Company's actual results in any endeavor may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, which factors or uncertainties may be beyond our ability to foresee or control. Other risk factors include the status of the Company's common stock as a "penny stock" and those risk factors stated in reports filed with the U.S. Securities and Exchange Commission or SEC on its EDGAR website (URL:www.sec.gov)

Contact:
Tom Wood
912-590-2001
twood@remsleep.com

View the original release on www.newmediawire.com


News Source: Remsleep Holdings


24.02.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Remsleep Holdings
United States
ISIN: US75990A2006
EQS News ID: 2090541

 
End of News EQS News Service

2090541  24.02.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2090541&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu REMSleep Holdings Inc Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Digital vs Kreditkarten: Wer gewinnt das Zahlungs-Rennen? – Wall Street Live mit Tim Schäfer

In der heutigen Ausgabe von Wall Street Live geht es um Digitale Zahlungssysteme. Warum haben Unternehmen wie Visa, Mastercard und American Express kaum Konkurrenz? Wo liegen die Probleme von PayPal und wird Apple Pay in Zukunft noch mehr im digitalen Zahlungsumfeld mitspielen? Diese und weitere Fragen beantwortet Tim Schäfer in der heutigen Ausgabe von Wall Street Live.

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Digital vs Kreditkarten: Wer gewinnt das Zahlungs-Rennen? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’504.67 18.21 S2S3VU
Short 13’748.32 13.61 B7ZS2U
Short 14’279.39 8.68 UIDBSU
SMI-Kurs: 12’953.17 24.02.2025 17:30:12
Long 12’381.51 19.30 BEQSJU
Long 12’140.00 13.93
Long 11’606.78 8.98 BBQSEU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten